Mu Yang is a behavioral neuroscientist and the director of the Mouse NeuroBehavior Core at Columbia University Medical Center. She received training in animal behavior and neuroethology in the lab of the late Robert Blanchard at the University of Hawaii, where she earned her Ph.D. In 2006, she joined the lab of Jacqueline Crawley at the National Institute of Mental Health for postdoctoral training. She spent 2012 to 2016 as an assistant professor in the department of psychiatry and behavioral sciences and a faculty member at the MIND Institute at the University California, Davis. In 2016, she joined Columbia’s Institute for Genomic Medicine to lead the university’s first centralized state-of-the-art mouse behavior phenotyping facility. Since summer 2017, her team has provided testing and data analysis services to over 30 Columbia research groups.
Mu Yang
Director of the Mouse NeuroBehavior Core
Columbia University Medical Center
Explore more from The Transmitter
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.